Lexicon Pharmaceuticals, Novo Nordisk strike obesity-drug license deal worth up to $1B
Lexicon Pharmaceuticals Inc. (Nasdaq: LXRX) said March 28 it will exclusively license its drug candidate LX9581 to Danish ...
Pain Relief Without Addiction: Researchers Develop New Oxytocin-Based Oral Drug
Researchers have developed a new type of oral painkiller for chronic abdominal pain, inspired by the peptide hormone oxytocin, which is known for triggering contractions during childbirth. Researchers ...